Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1 Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 83 Carboplatin 78 Magnetic Resonance Spectroscopy 68 Specimen Handling 66 Cisplatin 63 Paclitaxel 58 Gemcitabine 50 Docetaxel 40 Dexamethasone 38 Cyclophosphamide 37 Oxaliplatin 35 Fluorouracil 35 Radiotherapy 34 Leucovorin 34 Doxorubicin 34 Radiation 33 Pemetrexed 33 Bevacizumab 31 Capecitabine 30 durvalumab 27 Etoposide 27 Vincristine 26 Rituximab 26 Nivolumab 24 Prednisone 23 Letrozole 23 Irinotecan 23 Taxes 22 Lenalidomide 22 Biopsy 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Bupropion × 30 days × Clear all

NCT05646862 2026-05-06

INAVO121

Hoffmann-La Roche

Phase 3 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡